Welcome to the Gutmann Laboratory

For the past 25 years, the Gutmann laboratory has employed neurofibromatosis type 1 (NF1) as a model system to characterize the genomic, genetic, cellular and molecular factors that contribute to the disorders of the nervous system. The goal of this work is not only to establish new treatments for people with NF, but also to better understand related medical problems in the general population, including adult and childhood brain tumors, nerve tumors, cognitive deficits, and autism.